If patients with rs1564483 A allele were associated with a lower level of Bcl-2 protein, it may be biologically plausible that the decreased anti-apoptotic cellular defense of lung cancer cells may improve the efficacy of chemo- or radio-therapy strategies, and then lead to a favorable outcome of advanced NSCLC patients. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.